OpenAlex
PricingAboutJobs
Log inGet started
Work

Piragliatin (RO4389620), a Novel Glucokinase Activator, Lowers Plasma Glucose Both in the Postabsorptive State and after a Glucose Challenge in Patients with Type 2 Diabetes Mellitus: A Mechanistic Study

HTML

Year: 2010
Type: article
Study designs: Randomized Controlled Trial, Clinical Trial
Source: The Journal of Clinical Endocrinology & Metabolism
DOI: 10.1210/jc.2010-1041
Authors: Riccardo C. Bonadonna, Tim Heise, Christophe Arbet-Engels, Christoph Kapitza, Angelo Avogaro, Joe Grimsby, Jay Zhi, Joseph F. Grippo, Raffaella Balena
Institutions: University of Verona, University of Padua, Profil Institute for Metabolic Research, F. Hoffmann-La Roche AG
Language: English

Topic: Diabetes Treatment and Management
Subfield: Endocrinology, Diabetes and Metabolism
Field: Medicine
Domain: Health Sciences
Keywords: glucokinase activators, type 2 diabetes, beta-cell function, glucose homeostasis, oral glucose tolerance test, fasting blood glucose, glucose turnover, endogenous glucose production, glucose uptake
SDG: Good health and well-being

Open Access status: closed

Funders: Eli Lilly and Company, Roche, Università degli Studi di Verona
OpenAlex ID: W2013481385
FWCI: 10.33
Cites: 35
Cited by: 154
Related to: 10
OpenAlex
Nonprofit
Open DataOpen Data
Open Source
Product
Search
Compare
Pricing
Repositories
Unpaywall
Unsub
Developers
API docs
Data snapshot
Status
Source code
Organization
About
Team
Testimonials
Brand
Jobs
Community
Help center
Contact
Events
Blog
Mailing list
Subscribe
Supporters
Legal
Privacy
Accessibility
Terms
Security